Jiao Guohui, Huang Jian, Wu Bo, Hu Chunxiao, Gao Chenyang, Chen Wenhui, Huang Man, Chen Jingyu
Wuxi Lung Transplant Center, Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, China.
The Second Affiliated Hospital of Hainan Medical University, Hainan, China.
JACC Asia. 2022 Dec 15;2(7):819-828. doi: 10.1016/j.jacasi.2022.09.017. eCollection 2022 Dec.
Extracorporeal membrane oxygenation (ECMO) has been used as intraoperative hemodynamic support in patients with end-stage lung diseases and pulmonary hypertension undergoing lung transplantation (LT).
The aim of this study was to identify the association of pulmonary artery pressure change during ECMO and post-LT survival.
The study investigators collected and analyzed the data from Chinese Lung Transplantation Registry. Patients who have severe pulmonary hypertension with intraoperative ECMO support were enrolled. Post-LT mortality and morbidity were further collected and compared.
A total of 208 recipients were included in the study, during which 53 deaths occurred post-LT. All the patients had severe pulmonary hypertension and were supported by intraoperative ECMO. Using eXtreme Gradient Boosting, or XGboost, model method, 20 variables were selected and ranked. Changes of mean pulmonary artery pressure at the time of ECMO support and ECMO wean-off (ΔmPAP) were related to post-LT survival, after adjusting for potential confounders (recipient age, New York Heart Association functional class status before LT, body mass index, pre-LT hypertension, pre-LT steroids, and pre-LT ECMO bridging). A nonlinear relationship was detected between ΔmPAP and post-LT survival, which had an inflection point of 35 mm Hg. Recipients with ΔmPAP ≦35 mm Hg had higher mortality rate calculated through the Kaplan-Meier estimator ( 0.041). Interaction analysis showed that recipients admitted in LT center with high case volume (≥50 cases/year) and ΔmPAP 35 mm Hg had better long-term survival. The trend was reversed in recipients who were admitted in LT center with low case volume (<50 cases/year).
The relationship between ΔmPAP and post-LT survival was nonlinear. Optimal perioperative ECMO management strategy with experienced team is further warranted.
体外膜肺氧合(ECMO)已被用作终末期肺病和肺动脉高压患者肺移植(LT)术中的血流动力学支持。
本研究旨在确定ECMO期间肺动脉压力变化与LT术后生存率之间的关联。
研究调查人员收集并分析了中国肺移植登记处的数据。纳入术中接受ECMO支持的重度肺动脉高压患者。进一步收集并比较LT术后的死亡率和发病率。
本研究共纳入208例受者,其中53例在LT术后死亡。所有患者均患有重度肺动脉高压,并在术中接受了ECMO支持。使用极端梯度提升(XGboost)模型方法,选择并排列了20个变量。在调整潜在混杂因素(受者年龄、LT术前纽约心脏协会功能分级状态、体重指数、LT术前高血压、LT术前使用类固醇以及LT术前ECMO桥接)后,ECMO支持时和ECMO撤机时平均肺动脉压力的变化(ΔmPAP)与LT术后生存率相关。检测到ΔmPAP与LT术后生存率之间存在非线性关系,拐点为35mmHg。通过Kaplan-Meier估计器计算,ΔmPAP≤35mmHg的受者死亡率较高(0.041)。交互分析表明,在高病例量(≥50例/年)的LT中心接受治疗且ΔmPAP>35mmHg的受者长期生存率更高。在低病例量(<50例/年)的LT中心接受治疗的受者中,情况则相反。
ΔmPAP与LT术后生存率之间的关系是非线性的。进一步需要经验丰富的团队制定最佳的围手术期ECMO管理策略。